Rchr
J-GLOBAL ID：201901011772927093
Update date: Jun. 05, 2026
MATSUURA Kazuo
マツウラ カズオ | MATSUURA Kazuo
Affiliation and department：
Job title：
Professor
Papers (10)：
-
Kei Yamaguchi, Masahiro Ohara, Kazuo Matsuura, Hiroshi Ishiguro, Akihiko Osaki, Takao Takahashi, Hideki Onishi, Toshiaki Saeki. A case of recurrent breast cancer with severe hepatic dysfunction: Integrating narrative-based medicine and clinical decision-making. Palliative & supportive care. 2026. 24. e141
-
Nakayama T, Niikura N, Yamanaka T, Yamamoto M, Matsuura K, Inoue K, Takahara S, Nomura H, Kita S, Yamaguchi M, et al. Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM). Breast Cancer. 2024. 31. 6. 1167-1175
-
Hiroko Shimada, Akihiro Fujimoto, Kazuo Matsuura, Shunsuke Kohyama, Asami Nukui, Yuki Ichinose, Aya Asano, Masahiro Ohara, Hiroshi Ishiguro, Akihiko Osaki, et al. Comprehensive prognostic prediction of metastatic breast cancer treated with eribulin using blood-based parameters and ratio. Molecular and Clinical Oncology. 2024. 20. 15
-
Naoki Niikura, Takashi Yamanaka, Hironori Nomura, Kazuhiro Shiraishi, Hiroki Kusama, Mitsugu Yamamoto, Kazuo Matsuura, Kenichi Inoue, Sachiko Takahara, Shosuke Kita, et al. Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM). NPJ Breast Cancer. 2023. 9. 82
-
松浦 一生, 宮崎 千晶. 乳がん診療最前線の現場から 2023 「mammodite」導入で実現した理想的な教育体制. INNERVISION. 2023. 38. 8. 46-47
ｍore...
Lectures and oral presentations (16)：
-
The effectiveness of post-T-DXd treatments in patients with HER2-positive metastatic breast cancer: A nationwide Japanese cohort study (EN-SEMBLE)
(San Antonio Breast Cancer Symposium 2024 2024)
-
神経線維腫症1型に 乳癌が発症した一例
(第20回日本乳癌学会関東地方会 2024)
-
The impact of BRCA genetic testing on surgical selection in breast cancer patients.
(第69回日本人類遺伝学会 2024)
-
With Coronaにおけるペグフィルグラスチム投与状況の検討
(第32回日本乳癌学会学会 2024)
-
BM/LMCを伴うHER2陽性乳癌に対するT-DXdの治療効果 ROSET-BM OS update
(第32回日本乳癌学会 2024)
ｍore...
Return to Previous Page
